LivaNova (LIVN) Share-based Compensation Growth (3y) (2019 - 2026)
LivaNova (LIVN) Share-based Compensation Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.91 Bn | 193.31 Bn | 7.27 Bn | 8.37% |
| 2 | Stryker | 127.59 Bn | 124.11 Bn | 4.50 Bn | -28.31% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 73.24 Bn | 72.70 Bn | 3.85 Bn | 13.19% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 4.11% |
| 6 | Dexcom | 34.38 Bn | 32.44 Bn | 830.00 Mn | -0.59% |
| 7 | GE HealthCare Technologies | 33.96 Bn | 31.85 Bn | 2.18 Bn | 17.13% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 36.49% |
| 9 | Steris | 23.08 Bn | 22.60 Bn | 684.20 Mn | 3.40% |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn | 43.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 43.52% |
| Mar 31, 2026 | 73.74% |
| Dec 31, 2025 | -59.72% |
| Sep 30, 2025 | -26.49% |
| Jun 30, 2025 | -32.74% |
| Mar 31, 2025 | -8.79% |
| Dec 31, 2024 | -11.40% |
| Sep 30, 2024 | -8.36% |
| Jun 30, 2024 | -6.14% |
| Mar 31, 2024 | 2.36% |
| Dec 31, 2023 | 50.10% |
| Sep 30, 2023 | -47.14% |
| Jun 30, 2023 | -24.71% |
| Mar 31, 2023 | -44.13% |
| Dec 31, 2022 | 140.90% |
| Sep 30, 2022 | 183.86% |
| Jun 30, 2022 | 118.19% |
| Mar 31, 2022 | 30.58% |
| Dec 31, 2021 | 21.75% |
| Sep 30, 2021 | 15.78% |